These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24886896)
41. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients. Beldì D; Jereczek-Fossa BA; D'Onofrio A; Gambaro G; Fiore MR; Pia F; Chiesa F; Orecchia R; Krengli M Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1051-8. PubMed ID: 17716824 [TBL] [Abstract][Full Text] [Related]
42. Management of unknown primary tumor. Chepeha D; Koch W; Pitman K Head Neck; 2003 Jun; 25(6):499-504. PubMed ID: 12784242 [No Abstract] [Full Text] [Related]
44. [Lymph node metastases in the neck of unknown primary tumor]. Koscielny S; Gudziol H; Kretzschmar J Laryngorhinootologie; 2000 Aug; 79(8):483-9. PubMed ID: 11006913 [TBL] [Abstract][Full Text] [Related]
45. Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO). Müller von der Grün J; Bon D; Rödel C; Balermpas P Strahlenther Onkol; 2018 Aug; 194(8):750-758. PubMed ID: 29761228 [TBL] [Abstract][Full Text] [Related]
46. Benefit of postoperative chemoradiotherapy for patients with unknown primary squamous cell carcinoma of the head and neck. Shehadeh NJ; Ensley JF; Kucuk O; Black C; Yoo GH; Jacobs J; Lin HS; Heilbrun LK; Smith D; Kim H Head Neck; 2006 Dec; 28(12):1090-8. PubMed ID: 16933316 [TBL] [Abstract][Full Text] [Related]
47. Unknown primary cancer of the head and neck: a multidisciplinary approach. Cerezo L; Raboso E; Ballesteros AI Clin Transl Oncol; 2011 Feb; 13(2):88-97. PubMed ID: 21324796 [TBL] [Abstract][Full Text] [Related]
49. Cancer of unknown primary in the head and neck: Diagnosis and treatment. Ota I; Kitahara T Auris Nasus Larynx; 2021 Feb; 48(1):23-31. PubMed ID: 32888761 [TBL] [Abstract][Full Text] [Related]
51. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma. Maulard C; Housset M; Brunel P; Huart J; Ucla L; Rozec C; Delanian S; Baillet F Laryngoscope; 1992 Aug; 102(8):884-90. PubMed ID: 1495353 [TBL] [Abstract][Full Text] [Related]
52. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma. Park JM; Jung CK; Choi YJ; Lee KY; Kang JH; Kim MS; Hu HJ Hum Pathol; 2010 Mar; 41(3):431-7. PubMed ID: 19954817 [TBL] [Abstract][Full Text] [Related]
53. Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes. Doty JM; Gossman D; Kudrimoti M; Valentino J; Arnold S; Spring PM J Ky Med Assoc; 2006 Feb; 104(2):57-64. PubMed ID: 16594571 [TBL] [Abstract][Full Text] [Related]
54. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection. Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869 [TBL] [Abstract][Full Text] [Related]
55. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501 [TBL] [Abstract][Full Text] [Related]
56. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Bhide S; Clark C; Harrington K; Nutting CM Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198 [TBL] [Abstract][Full Text] [Related]
57. Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site. Galloway TJ; Ridge JA J Clin Oncol; 2015 Oct; 33(29):3328-37. PubMed ID: 26351351 [TBL] [Abstract][Full Text] [Related]
59. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340 [TBL] [Abstract][Full Text] [Related]
60. CUP (carcinoma of unknown primary) syndrome in head and neck: clinic, diagnostic, and therapy. Weber A; Schmoz S; Bootz F Onkologie; 2001 Feb; 24(1):38-43. PubMed ID: 11441279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]